News
December 17, 2015
15 Democrat and 29 Republican U.S. Representatives, representing 23 states, cosigned a December 16, 2015, letter to CMS Acting Administrator Andy Slavitt expressing concerns with CMS's proposed regulations implementing the Protecting Access To Medicare Act of 2014 (PAMA).
-
Follow up to the December 16, 2015, letter signed by 44 U.S. Representatives
If your Representative SIGNED the letter, please them an email, thanking them for their leadership and support. Tell them that you will need their support in 2016 to address this issue as it moves forward. If your Representative DID NOT sign the letter; please save and forward them a copy of the letter via email; tell them that you wanted to bring this important issue to their attention; ask for their support going forward because this is an issue that threatens your laboratory business.
-
Congressional Site Visits to Your Laboratory:
Every NILA member should make an effort to invite the Representative(s) from the district where your laboratory is headquartered or has operations and the Senators from your laboratory’s state to visit the laboratory in the first quarter of 2016. Such requests can be made by calling your congressional offices and asking to speak with the scheduler. Written requests will be required via form letter (to be provided by the specific congressional office) or through a letter request. Please alert NILA by telephone: (314)241-1445 or email: nila@nila-usa.org when you have scheduled such a site visit so that we can help provide talking points and recommendations. The purpose of the visits is to get members of Congress to understand how a laboratory business operates; who you employ; and who you provide services to in the district/state. It is critically important that members of Congress learn more about the work of your laboratory so that they are better prepared to help NILA in addressing policies that affect your business.